Under new the FDA policy, commercial manufacturers will submit emergency use authorization requests for COVID-19 serology tests. The FDA released this policy following concerns regarding serology tests.

The White House published a “National Testing Blueprint” on April 27 in response to growing criticism regarding availability of testing. The CAP remains engaged with the Trump Administration and Congress regarding its response to the COVID 19 pandemic, including testing, and will be reviewing certain elements of the blueprint.

On April 3, federal assistance programs, such as the Paycheck Protection Program, began offering loans to small businesses. The Coronavirus Aid, Relief, and Economic Security (CARES) Act created more than $350 billion in emergency aid for small businesses during the COVID-19 national emergency and economic downturn.

Through a strategic advocacy campaign deploying the necessary resources only the CAP can provide, the CAP persuaded the federal government to issue a waiver that allows pathologists to work remotely during this national emergency.

The House Ways & Means Committee overwhelmingly voted to support the CAP-backed Consumer Protections Against Surprise Medical Bills Act of 2020 to resolve billing disputes between insurers and physicians.